BioMarin Pharmaceutical (NASDAQ:BMRN) executives highlighted a three-pillar strategy focused on growth, innovation, and “value commitment” during a fireside chat hosted by Leerink Partners’ Joe ...

The approval follows PEGASUS Phase III trial assessing Palynziq efficacy and safety compared to diet alone in adolescents ...

BioMarin Pharmaceutical (NASDAQ:BMRN) executives used a fireside chat at TD Cowen’s 46th Annual Healthcare Conference to ...

Investors in BioMarin Pharmaceutical Inc. BMRN need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $70 Put had some of the highest ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsBrian Mueller - ...

・The deal values Amicus at $14.50 per share, representing a 33% premium to its $10.90 closing price on Thursday. ・Amicus settled its patent dispute with Indian drugmakers Aurobindo Pharma and Lupin ...

BioMarin Pharmaceutical's (NASDAQ: BMRN) website doesn't show any scheduled events on its calendar over the next month. However, that means nothing. The drugmaker will almost certainly report its 2025 ...

On Friday, the U.S. Food and Drug Administration (FDA) approved BioMarin Pharmaceutical Inc.’s supplemental application for ...

Gregory Friberg, EVP at BioMarin Pharmaceutical (NASDAQ:BMRN), executed a substantial insider sell on February 27, according to an SEC filing. What Happened: Friberg's decision to sell 6,326 shares of ...

BioMarin Pharmaceutical today announced that the US Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for Palyvziq (pegvaliase-pqpz) to ...

5 analysts have expressed a variety of opinions on BioMarin Pharmaceutical (NASDAQ:BMRN) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent ...

Good morning, and welcome once again to TD Cowen's 46th Annual Healthcare Conference. I'm Phil Nadeau, one of the biotech analysts here at Cowen, and it's my pleasure to do a fireside chat with ...